Titre : Techniques de chimie combinatoire

Techniques de chimie combinatoire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reproducibility of Results
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Techniques de chimie combinatoire : Questions médicales les plus fréquentes", "headline": "Techniques de chimie combinatoire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Techniques de chimie combinatoire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-27", "dateModified": "2025-03-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Techniques de chimie combinatoire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Techniques de chimie synthétique", "url": "https://questionsmedicales.fr/mesh/D060326", "about": { "@type": "MedicalCondition", "name": "Techniques de chimie synthétique", "code": { "@type": "MedicalCode", "code": "D060326", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.897.836.249" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Technique SELEX", "alternateName": "SELEX Aptamer Technique", "url": "https://questionsmedicales.fr/mesh/D052156", "about": { "@type": "MedicalCondition", "name": "Technique SELEX", "code": { "@type": "MedicalCode", "code": "D052156", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.897.836.249.249.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Techniques de chimie combinatoire", "alternateName": "Combinatorial Chemistry Techniques", "code": { "@type": "MedicalCode", "code": "D020650", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anna K H Hirsch", "url": "https://questionsmedicales.fr/author/Anna%20K%20H%20Hirsch", "affiliation": { "@type": "Organization", "name": "Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), 66123, Saarbrücken, Germany. anna.hirsch@helmholtz-hips.de." } }, { "@type": "Person", "name": "Lei Hu", "url": "https://questionsmedicales.fr/author/Lei%20Hu", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Jiangsu University, 301 Xuefu Rd., Zhenjiang, China. Electronic address: leihu@ujs.edu.cn." } }, { "@type": "Person", "name": "Shuang Zhao", "url": "https://questionsmedicales.fr/author/Shuang%20Zhao", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Jiangsu University, 301 Xuefu Rd., Zhenjiang, China." } }, { "@type": "Person", "name": "Yao Wu", "url": "https://questionsmedicales.fr/author/Yao%20Wu", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Jiangsu University, 301 Xuefu Rd., Zhenjiang, China." } }, { "@type": "Person", "name": "Mijanur R Molla", "url": "https://questionsmedicales.fr/author/Mijanur%20R%20Molla", "affiliation": { "@type": "Organization", "name": "Institute of Biological and Chemical Systems-Functional Molecular Systems (IBCS-FMS), Karlsruhe Institute of Technology (KIT), Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.", "datePublished": "2023-08-08", "url": "https://questionsmedicales.fr/article/37551542", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dom.15217" } }, { "@type": "ScholarlyArticle", "name": "Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay.", "datePublished": "2023-03-09", "url": "https://questionsmedicales.fr/article/36892725", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10549-023-06888-1" } }, { "@type": "ScholarlyArticle", "name": "Reproducible Abnormalities and Diagnostic Generalizability of White Matter in Alzheimer's Disease.", "datePublished": "2023-04-04", "url": "https://questionsmedicales.fr/article/37014553", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12264-023-01041-w" } }, { "@type": "ScholarlyArticle", "name": "Support academic access to automated cloud labs to improve reproducibility.", "datePublished": "2023-01-03", "url": "https://questionsmedicales.fr/article/36595506", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pbio.3001919" } }, { "@type": "ScholarlyArticle", "name": "Reproducibility assessment of uptake on dedicated breast PET for noise discrimination.", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36434200", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12149-022-01809-6" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Technologie", "item": "https://questionsmedicales.fr/mesh/D013672" }, { "@type": "ListItem", "position": 4, "name": "Technologie pharmaceutique", "item": "https://questionsmedicales.fr/mesh/D013678" }, { "@type": "ListItem", "position": 5, "name": "Techniques de chimie synthétique", "item": "https://questionsmedicales.fr/mesh/D060326" }, { "@type": "ListItem", "position": 6, "name": "Techniques de chimie combinatoire", "item": "https://questionsmedicales.fr/mesh/D020650" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Techniques de chimie combinatoire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Techniques de chimie combinatoire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Techniques de chimie combinatoire", "description": "Comment la chimie combinatoire aide-t-elle au diagnostic ?\nQuels outils sont utilisés pour le diagnostic en chimie combinatoire ?", "url": "https://questionsmedicales.fr/mesh/D020650?mesh_terms=Reproducibility+of+Results&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Techniques de chimie combinatoire", "description": "Quels symptômes peuvent être ciblés par des composés issus de la chimie combinatoire ?\nLa chimie combinatoire peut-elle aider à identifier des symptômes ?", "url": "https://questionsmedicales.fr/mesh/D020650?mesh_terms=Reproducibility+of+Results&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Techniques de chimie combinatoire", "description": "La chimie combinatoire joue-t-elle un rôle dans la prévention des maladies ?\nQuels composés préventifs sont issus de la chimie combinatoire ?", "url": "https://questionsmedicales.fr/mesh/D020650?mesh_terms=Reproducibility+of+Results&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Techniques de chimie combinatoire", "description": "Quels types de traitements sont développés par la chimie combinatoire ?\nComment la chimie combinatoire améliore-t-elle les traitements ?", "url": "https://questionsmedicales.fr/mesh/D020650?mesh_terms=Reproducibility+of+Results&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Techniques de chimie combinatoire", "description": "Quelles complications peuvent survenir avec des traitements issus de la chimie combinatoire ?\nComment minimiser les complications des traitements ?", "url": "https://questionsmedicales.fr/mesh/D020650?mesh_terms=Reproducibility+of+Results&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Techniques de chimie combinatoire", "description": "Quels facteurs de risque sont pris en compte en chimie combinatoire ?\nComment la chimie combinatoire évalue-t-elle les facteurs de risque ?", "url": "https://questionsmedicales.fr/mesh/D020650?mesh_terms=Reproducibility+of+Results&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment la chimie combinatoire aide-t-elle au diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de créer des bibliothèques de composés pour identifier des biomarqueurs." } }, { "@type": "Question", "name": "Quels outils sont utilisés pour le diagnostic en chimie combinatoire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la spectrométrie de masse et la chromatographie sont courantes." } }, { "@type": "Question", "name": "Quels symptômes peuvent être ciblés par des composés issus de la chimie combinatoire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes variés comme la douleur, l'inflammation ou des troubles neurologiques." } }, { "@type": "Question", "name": "La chimie combinatoire peut-elle aider à identifier des symptômes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en développant des molécules qui interagissent avec des cibles biologiques spécifiques." } }, { "@type": "Question", "name": "La chimie combinatoire joue-t-elle un rôle dans la prévention des maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en développant des agents préventifs et des vaccins ciblés." } }, { "@type": "Question", "name": "Quels composés préventifs sont issus de la chimie combinatoire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs d'enzymes ou des modulateurs de récepteurs pour prévenir des maladies." } }, { "@type": "Question", "name": "Quels types de traitements sont développés par la chimie combinatoire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements pour des maladies comme le cancer, le diabète et les infections." } }, { "@type": "Question", "name": "Comment la chimie combinatoire améliore-t-elle les traitements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de découvrir des médicaments plus efficaces et avec moins d'effets secondaires." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des traitements issus de la chimie combinatoire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des réactions allergiques ou des résistances médicamenteuses." } }, { "@type": "Question", "name": "Comment minimiser les complications des traitements ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "En optimisant la structure des composés pour réduire les effets indésirables." } }, { "@type": "Question", "name": "Quels facteurs de risque sont pris en compte en chimie combinatoire ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme la génétique, l'environnement et le mode de vie des patients." } }, { "@type": "Question", "name": "Comment la chimie combinatoire évalue-t-elle les facteurs de risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "En développant des modèles prédictifs basés sur des données biologiques et chimiques." } } ] } ] }

Sources (10000 au total)

Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.

To reassess the 6-month efficacy and to assess the 12-month sustained efficacy of the MiniMed™ 780G advanced hybrid closed-loop automated insulin delivery (AID) system compared to multiple daily injec... The ADAPT study was a prospective, multicentre, open-label, randomized control trial in people with type 1 diabetes, with a glycated haemoglobin (HbA1c) concentration of at least 8.0% (64 mmol/mol), o... A total of 39 SWITCH and 36 SUSTAIN participants entered the continuation phase. In the SWITCH group, HbA1c was significantly decreased by -1.4% (95% confidence interval [CI] -1.7% to -1.1%; P < 0.001... ADAPT study phase glycaemic improvements were reproduced and sustained in the continuation phase, supporting the early adoption of AID therapy in people with type 1 diabetes not meeting glucose target...

Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay.

The PAM50 assay is used routinely in clinical practice to determine breast cancer prognosis and management; however, research assessing how technical variation and intratumoral heterogeneity contribut... We evaluated the impact of intratumoral heterogeneity on the reproducibility of results for the PAM50 assay by testing RNA extracted from formalin-fixed paraffin embedded breast cancer blocks sampled ... Technical replicates (N = 144) achieved 93% agreement for ROR-P group and 90% agreement on PAM50 subtype. For spatially distinct biological replicates (N = 40 intratumoral replicates), agreement was l... The PAM50 assay achieved very high technical reproducibility for breast cancer subtyping and ROR-P, but intratumoral heterogeneity is revealed by the assay in a small proportion of cases....

Reproducibility assessment of uptake on dedicated breast PET for noise discrimination.

Dedicated breast PET (dbPET) systems have improved the detection of small breast cancers but have increased false-positive diagnoses due to an increased chance of noise detection. This study examined ... This study included 21 patients with newly diagnosed breast cancer who underwent [... A total of 213 indexed uptake spots were identified on dbPET-1, including 152, 15, 6, 6, and 34 lesions classified as BI-RADS MRI categories 1, 2, 4b, 4c, and 5, respectively. Overall, 31.9% of the in... Our results demonstrated that reproducibility assessment helped reduce false-positive findings caused by noise on dbPET without lowering the sensitivity for malignancy. While subjective visual assessm...

Interlaboratory reproducibility of a touch-transfer assay for the assessment of antimicrobial surfaces.

Various assay methods have been developed to study antimicrobial activity based on contamination of surfaces with different amounts of liquid bacterial suspensions. Since surfaces with frequent hand c... To investigate a surface previously confirmed to display antimicrobial activity even after drying of small volumes of bacterial suspension (Egger antimicrobial surfaces: EAS) under conditions modellin... EAS, an antimicrobial copper alloy, as well as a negative control were examined to assess interlaboratory test reproducibility.... Significantly fewer bacteria on EAS after touch transfer and some differences in the touch transmission were detected between the two laboratories. However, an identical assessment of effectiveness fo... Since, in the real world of a hospital, organisms are typically transferred between dry surfaces, further standardization of the touch-transfer method is worthwhile for a better understanding of the e...

Repeatability and reproducibility of a hyperspectral imaging system for in vivo color evaluation.

Color imaging is a tried and true method for the evaluation of cosmetic and dermatological effects, but it fails to capture all the information in a scene's spectral reflectance. For this reason, ther... We developed a novel HyperSpectral Imager (HSI) able to take in vivo full-face format images as a next generation instrument for skin color measurement and beyond. Here, we report part of the results ... We find that the measurements from the HSI provide repeatability and reproducibility as good or better than those of our previous benchmark devices.... From these results, we conclude that not only is the HSI suitable for use in color evaluation studies, but also that it gives operational advantages over the previous generation of evaluation instrume...